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Abstract
Objective: Patients with irreversible pulmonary vascular obstructive disease caused by pulmonary hypertension due to congenital heart
defects are considered either inoperable or only candidates to lung transplantation. This study evaluated an experimental model of surgically
induced unilateral pulmonary hypertension. Methods: In eight pigs, 2-months-old, the left pulmonary artery was divided at the origin and
end-to-side anastomosed to the descending thoracic aorta through a left thoracotomy. In this way, increased pulmonary blood flow in the right
lung and systemic perfusion pressure and oxygenation in the left lung were obtained. After an interval of 6–12 weeks the animals underwent
cardiac catheterization and were then sacrificed. Histological examination was done on both the lungs. Results: The mean left-to-right shunt
through the left pulmonary artery diminished from 58.9 ^ 9.6% at the end of the procedure to 4.5 ^ 1.5% at the latest hemodynamic
evaluation ðP , 0:01Þ. Pressures and saturations remained identical in aorta and left pulmonary artery, without reduction (NS) with
FiO2 ¼ 1.0 ventilation; in the right pulmonary artery there was a mild elevation of the pressures, but still responsive ðP , 0:05Þ to
FiO2 ¼ 1.0 ventilation. Lung histology showed normal right pulmonary arteries, but irreversible vascular lesions like intimal fibrosis, medial
hypertrophy, vascular occlusions, plexiform and dilatation lesions in all the left lungs. Conclusions: The lung exposed to systemic pressure
and oxygenation develops irreversible vascular lesions typical of pulmonary vascular obstructive disease. The lung exposed to increased flow
shows only mild elevation of the arterial pressure, remains responsive to oxygen vasodilatation, and displays normal histology.
q 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Survival for patients with Eisenmenger syndrome
(irreversible pulmonary vascular obstructive disease with
elevated pulmonary vascular resistance and right-to-left
shunt as a consequence of a congenital heart defect with a
connection between the systemic and the pulmonary
circulations) has not improved substantially in the past
several decades. The quality of life is universally altered by
the presence of cyanosis, exercise intolerance, and the
comorbid conditions associated with erythtocytosis such as
thromboembolic events and cerebrovascular complications
[1–8]. Pregnancy and non-cardiac surgery are associated
with high mortality rate in patients with Eisenmenger
syndrome [4,5,9,10].
Several experimental models of pulmonary hypertension
have been reported in the literature review [11–22], but all
of them failed to reproduce a situation with adequate and
simultaneous increase of pulmonary blood flow, pressure
and oxygen saturation in one lung. In order to reproduce a
situation in the pulmonary circulation similar to the
Eisenmenger syndrome, we designed an experimental
study with the surgical creation of a unilateral pulmonary
hypertension, obtained by division of the left pulmonary
artery at the origin and its anastomosis end-to-side to the
descending thoracic aorta. In this way, we created a model
with the left lung perfused with elevated blood flow,
systemic pressure and oxygen saturation, while the right
lung remained as the control lung, perfused with the same
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pressure and oxygen saturation, but with increased blood
flow.
2. Materials and methods
All animals received human care in compliance with the
‘Principles of Laboratory Animals’ formulated by the
National Society of Medical Research and the Guide for
the Care and Use of Laboratory Animals prepared by the
Institute of Laboratory Animal Resources and published by
the National Institutes of Health (NIH publication 85-23,
revised 1985). The protocol was approved by the insti-
tutional Committee on Animal Research.
2.1. Surgical technique
Eight domestic pigs, 2 months of age and with a body
weight of 30 ^ 2 kg, received i.m. ketamine 15 mg/kg,
azaperon 0.5 mg, atropine 2 mg and penicillin G
1,000,000 IU. General anesthesia was induced and main-
tained with inhaled isoflurane 1.5%, with tracheal intubation
and mechanical ventilation. Electrocardiogram (EKG),
percutaneous arterial O2 saturation and expired CO2 were
continuously monitored. Through a left thoracotomy in the
fourth intercostal space, the hemiazygos vein was divided,
the descending thoracic aorta and the left pulmonary artery
were dissected free, and 1 mg/kg of heparin was given i.v.
After division of the left pulmonary artery at its origin and
suture of the proximal stump, an end-to-side anastomosis
was performed with 6/0 polypropylene running sutures
between the descending thoracic aorta and distal stump of
the left pulmonary artery (Fig. 1A). Vascular clamps were
utilized for the temporary control of the left pulmonary
artery and the descending thoracic aorta during the
confection of the anastomosis. Immediately after opening
of the vascular clamps, furosemide 1 mg/kg i.v. was given,
and dopamine 5 mg/kg i.v. infusion was started, until the
end of the procedure, to prevent or reduce the negative
consequences of the suddenly induced unilateral pulmonary
edema, observed in the first animal of this experimental
study, which died shortly after the tracheal extubation. The
accomplishment of an unrestricted anastomosis was verified
by the presence of a continuous thrill on the distal left
pulmonary artery and by direct pressure measurement in
both the aorta and the left pulmonary artery in order to
demonstrate identical values. Flow-meters were applied to
the descending thoracic aorta and the left pulmonary artery.
After insertion of a 24Fr chest drainage, the thoracotomy
was closed and the animal was awakened and extubated.
The chest drainage remained in place until the whole air in
the left pleural space was evacuated (usually 2–4 h).
Animals were then sent back to the farm, where they
received furosemide 40 mg/day/7 days per os. No antic-
oagulant or antiplatelet agents were given.
2.2. Assessments
After an interval of 6–12 weeks, under the same general
anesthesia and monitoring used for the first procedure, the
left carotid artery was isolated and through an 8Fr
Fig. 1. (A) Intra-operative photograph of the end-to-side anastomosis of the
left pulmonary artery (LPA), divided at the origin, and the descending
thoracic aorta (DTA). (B) Post-mortem macroscopic aspect of the
anastomosis between descending thoracic aorta and left pulmonary artery.
Fig. 2. Histology (van Gieson–elastin stain) of the right lung after 12
weeks, showing a pulmonary artery with normal morphology.
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introducer a 6Fr angiography’s catheter was inserted to
retrograde reach the descending thoracic aorta and the left
pulmonary artery. The Intra Vascular Ultra Sound probe
was inserted to acquire data on anastomotic cross-sectional
area, with the EKG used as a trigger in order to distinguish
the systolic versus the diastolic measurements. Color
Doppler echocardiography was also performed. After
median sternotomy and longitudinal pericardiotomy, flow-
meters were applied to the ascending aorta and the main
pulmonary artery. Pressures and oxygen saturation were
measured on room air (FiO2 ¼ 0.21) and after 30 min with
100% oxygen ventilation (FiO2 ¼ 1.0) in right and left
atrium, aorta, left and right pulmonary artery. Vascular
resistance through the left lung was calculated with the
following formula expressed as Units ¼ mmHg/l/min:
(mean left pulmonary artery pressure 2 mean left atrial
pressure) divided by flow through the left pulmonary artery.
After hemodynamic measurements were obtained, the
animals were sacrificed. Macroscopic (Fig. 1B)and histo-
logic examinations were done on both lungs and the
anastomosis.
Student’s t-test has been used for statistical evaluation.
Data are expressed as mean ^ SD. The significance level
was P ¼ 0:05.
2.3. Instrumentation
2.3.1. Pressure measurement
Pressures were obtained using high-fidelity pressure
probe (Millar Mikro-Tip, model MPC-500) with a pressure
range of 250 to 300 mmHg and a sensitivity of
5 mV/V/mmHg.
2.3.2. Flow-meter measurements
Medi–Stim perivascular flow-meter probes were used, 8
and 12 mm in size, with a flow accuracy of 1%, resolution of
1 ml/min and flow sample rates were 333 Hz.
Left pulmonary artery flow was calculated as the
difference between the ascending aorta and main pulmonary
artery flow, after having ruled out intra-cardiac defects by
color Doppler echocardiography and measurements of right
atrium and main pulmonary artery O2 saturations.
2.3.3. Tissue processing
Both lungs were fixed with 4% buffered formaldehyde by
tracheal perfusion and immersion during 24 h. Up to 15
tissue samples for each lung were taken from the central
(region of the anastomosis), post-central and peripheral
(sub-pleural) areas of the vascular tree and embedded in
paraffin. Histological slides were stained with hematox-
ylin–eosin as well as with a combination of van Gieson–
elastin stain. All slides were examined and the vascular
lesions graded according to the Heath–Edwards classifi-
cation [23] by one of us (C.Y.G.), unaware of the origin of
the specimens.
3. Results
As we already described in Section 2, the first pig died
shortly after tracheal extubation because of pulmonary
edema. Since then, all other animals have been treated with
furosemide 1 mg/kg i.v. after opening the vascular clamps,
dopamine 5 mg/kg i.v. until the end of the procedure and
furosemide 40 mg/day/7 days per os, to prevent or reduce
the negative consequences of the suddenly induced
unilateral pulmonary edema. With this strategy we were
able to extubate all other animals shortly after the end of the
procedure and to send them all back to the farm within the
same day.
The mean left-to-right shunt through the left pulmonary
artery (left pulmonary artery flow/ascending aorta flow)
diminished from 58.9 ^ 9.6% immediately at the end of the
surgical procedure to 4.5 ^ 1.5% at the latest hemodynamic
evaluation ðP , 0:01Þ, showing a significant increase of
pulmonary vascular resistance in the left lung from a mean
value of 19.3 Units at the end of the surgical procedure to a
mean value of 232.0 Units. Pressures and oxygen satur-
ations were identical in aorta and left pulmonary artery,
confirming the presence of an unrestricted end-to-side
anastomosis between descending thoracic aorta and left
pulmonary artery.
The latest hemodynamic evaluations (Table 1) showed
that while in the left hypertensive lung, despite 30 min
exposure to FiO2 ¼ 1.0, the pulmonary vascular resistance
failed to decrease with only a significant increase of the
systolic pressure and pO2, in the left pulmonary artery, the
right lung had only a mild elevation of the arterial pressures
and remained responsive to oxygen vasodilatation.
Lung histology showed normal morphology of pulmon-
ary arteries in all the specimens harvested from the right
lungs (Fig. 2).
Irreversible vascular lesions were present in all the left
lungs, with intimal fibrosis and medial hypertrophy (mean
Heath–Edwards score ¼ 4.4) in specimen harvested after
6–9 weeks of exposure to high pressure, flow and oxygen
saturation (Fig. 3), while vascular occlusions, plexiform and
dilatation lesions (mean Heath–Edwards score ¼ 5.6) were
present in specimen harvested after 12 weeks of pulmonary
hypertension (Fig. 4).
4. Discussion
A variety of congenital heart defects with intra-cardiac
communication, left-to-right shunt and increased pulmonary
blood flow may be complicated by the development of
pulmonary hypertension. Prolonged pulmonary hyperten-
sion may result in irreversible vascular lesions, leading to
pulmonary vascular obstructive disease and the correspond-
ing clinical pattern of Eisenmenger syndrome [1–10].
The severity of the vascular remodeling in the pulmonary
vessels appears in direct correlation with the increase of the
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pulmonary blood flow, the pressure and oxygen saturation at
which it is delivered, and the duration. Various experimental
models of pulmonary hypertension have been proposed
[11–22], but none of them with adequate and simultaneous
increase of pulmonary blood flow, pressure and oxygen
saturation in one lung, with the contra-lateral lung
remaining as the control lung.
The model we devised consists of a reproducible
experimental model with unilateral pulmonary hypertension
(left lung perfused with elevated blood flow, systemic
pressure and oxygen saturation), with the right lung
remaining as the control lung, perfused with normal
pressure and oxygen saturation with only increased blood
flow.
The significant increase of pulmonary vascular resistance
observed in the left lung after a period of exposure to
systemic pressure and oxygen saturation, together with the
concomitant irreversible vascular lesions, demonstrated at
histological level, confirm that our model developed a
clinico-pathological pattern of unilateral pulmonary vascu-
lar obstructive disease. The degree of gravity of the
observed vascular lesions, as expected, was correlated
with the duration of pulmonary hypertension.
Our model also confirmed that even a substantial
increase of pulmonary blood flow in the contra-lateral
lung, unaccompanied by increase in pressure and oxygen
saturation, was unable to determine any change in the
morphology of the pulmonary vessels, as well as in the
hemodynamics. The only consequence to the increased
pulmonary blood flow for the same duration was a mild
elevation of the pulmonary artery pressures, with preserved
reactive dilatation in response to inhaled oxygen.
Of course we are aware that our experimental model
reproduces the vascular changes present in Eisenmenger
syndrome, without the concomitant right ventricular
hypertrophy, but our purpose was to address the changes
in the pulmonary circulation, not on the myocardial
function.
In conclusion, this experimental model of unilateral
pulmonary hypertension reproduces the clinical and patho-
logical entity corresponding to the pulmonary vascular
obstructive disease developed in patients with Eisenmenger
syndrome.
The model may serve well in the following series of
studies:
† all investigations directed at the underlying mechanisms
responsible for pulmonary vascular disease caused by
increased blood flow, pressure and oxygen saturation;
† comparison between hypertensive versus normotensive
lung in the same subject with regard to pathophysiology,
gene expression as well as protein and product
Table 1
Data obtained from latest hemodynamic evaluation
Left pulmonary artery Right pulmonary artery
FiO2 ¼ 0.21 FiO2 ¼ 1.0 P value FiO2 ¼ 0.21 FiO2 ¼ 1.0 P value
Pressure (mmHg)
Systolic 77.8 ^ 13.1 97.0 ^ 11.3 ,0.05 29.2 ^ 3.7 23.0 ^ 2.2 ,0.05
Diastolic 46.2 ^ 13.4 54.0 ^ 11.1 NS 17.8 ^ 5.2 10.4 ^ 3.4 ,0.05
Mean 59.6 ^ 9.5 72.6 ^ 10.5 NS 23.4 ^ 4.4 16.2 ^ 2.8 ,0.05
O2 saturation (%) 97.2 ^ 2.4 100 ^ 0 NS 64.9 ^ 2.1 77.9 ^ 0.9 ,0.005
pO2 (kPa) 12.2 ^ 4.1 60.0 ^ 3.2 ,0.001 3.9 ^ 0.6 4.8 ^ 0.3 ,0.05
Fig. 3. Histology (van Gieson–elastin stain of the left lung after 9 weeks,
with medial and intimal hypertrophy.
Fig. 4. Histology (van Gieson–elastin stain of the left lung after 12 weeks
showing vascular occlusions, plexiform and dilatation lesions.
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formation;
† test the effects of interventions commonly used clini-
cally, such as inhaled nitric oxide, to treat pulmonary
hypertension;
† test new drugs potentially active on pulmonary hyperten-
sion; and
† device new strategies aiming at slowing the progression
of the pulmonary vascular obstructive disease.
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Appendix A. Conference discussion
Dr A. Haverich (Hannover, Germany): You know and I know that this
model is not new. There was Greek groups in the late ’60s who did
subclavian artery to the upper lobe branch of the pulmonary artery with a
similar effect on the histology.
I have two questions. One, what do you think would happen if you
would reverse this anastomosis? And have you done these experiments with
the question of spontaneous reversal of pulmonary hypertension?
And second, do you really think that this model mimics the
Eisenmenger situation since the right ventricle is not affected by the
disease?
Dr Corno: I’m aware of the shunt done with the left subclavian artery
on the upper lobe of the pulmonary artery. There is also more recent work
done in the United States, and published two years ago in the Journal of
Thoracic and Cardiovascular Surgery, with just the left upper lobe
involved. But in all the above studies, the problem is that there was no
one contralateral lung available with normal perfusion as a control lung.
This is what I consider an advantage of our model compared to the model
you just quoted.
In regard to your question, yes, of course, we studied this model
because, first of all, we wanted to validate the model. And, of course, we
have in mind the strategies that maybe you have seen in the second slide
when I talked about this procedure. So the plan is now, first of all, to
recreate the same model, to reduce the pulmonary artery pressure with
progressive banding into the left pulmonary artery, and to follow the
hemodynamic and then histological lesion. The question is, I’m sure, then if
the pulmonary artery pressure is going down when you band, because
we’ve already done this acutely in two animals. And regarding the pressure,
we were able to reduce the systolic pressure in the pulmonary artery to 50%
and to 60% of the systemic. So we can lower the pulmonary artery pressure.
Is this followed by a regression of what they call “irreversible
histological lesions”? At the moment it is just a dream, but we want to test
this hypothesis.
Regarding the right ventricle, we are not interested in the right ventricle.
If the right ventricle is able to work, sustaining increased pulmonary
vascular resistance and systemic pulmonary artery pressure, once you are
able to lower the pulmonary vascular resistance and pressure, the right
ventricle should be able to work anyway.
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